Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 GBX | -5.41% | +14.75% | -73.88% |
May. 10 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-73.88% | 17.39M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- STX Stock
- News Shield Therapeutics plc
- UK's Shield Therapeutics Names Chief Commercial Officer